Live attenuated vaccines against influenza; an historical review

By Wareing M.D.   Tannock G.A.  

Vaccine, Vol. 19, Iss. 25, 2001-05 ,pp. : 3320-3330

Elsevier

Access to resources Recommend Favorite

Prevention of influenza by the intranasal administration of cold-recombinant, live-attenuated influenza virus vaccine: importance of interferon- production and local IgA response

By Tomoda T.   Morita H.   Kurashige T.   Maassab H.F.  

Vaccine, Vol. 13, Iss. 2, 1995-02 ,pp. : 185-190

Elsevier

Access to resources Recommend Favorite

Cold-attenuated live influenza vaccines, a risk-benefit assessment

By Pfleiderer M.   Lower J.   Kurth R.  

Vaccine, Vol. 20, Iss. 5, 2001-12 ,pp. : 886-894

Elsevier

Access to resources Recommend Favorite

Evaluation of bivalent live attenuated influenza A vaccines in children 2 months to 3 years of age: safety, immunogenicity and dose-response

By Wyeth-Ayerst ca Influenza Vaccine Study Group   Gruber W.C.   Darden P.M.   Still J.G.   Lohr J.   Reed G.   Wright P.F.  

Vaccine, Vol. 15, Iss. 12, 1997-08 ,pp. : 1379-1384

Elsevier

Access to resources Recommend Favorite

Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine

By Nichol K.L.   Mallon K.P.   Mendelman P.M.  

Vaccine, Vol. 21, Iss. 17, 2003-05 ,pp. : 2216-2226

Elsevier

Access to resources Recommend Favorite